10-5903035-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_178150.3(FBH1):c.17G>A(p.Arg6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000751 in 1,611,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178150.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBH1 | NM_178150.3 | c.17G>A | p.Arg6Gln | missense_variant | 2/21 | ENST00000362091.9 | NP_835363.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBH1 | ENST00000362091.9 | c.17G>A | p.Arg6Gln | missense_variant | 2/21 | 1 | NM_178150.3 | ENSP00000355415.4 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000136 AC: 34AN: 249644Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134944
GnomAD4 exome AF: 0.0000754 AC: 110AN: 1459572Hom.: 0 Cov.: 31 AF XY: 0.0000716 AC XY: 52AN XY: 725938
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2022 | The c.170G>A (p.R57Q) alteration is located in exon 3 (coding exon 3) of the FBXO18 gene. This alteration results from a G to A substitution at nucleotide position 170, causing the arginine (R) at amino acid position 57 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at